Cerebrolysin
Cerebrolysin is a pharmaceutical drug with 32 clinical trials. Currently 3 active trials ongoing. Historical success rate of 83.3%.
Success Metrics
Based on 15 completed trials
Phase Distribution
Phase Distribution
5
Early Stage
5
Mid Stage
15
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
78.9%
15 of 19 finished
21.1%
4 ended early
3
trials recruiting
32
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Combined Cerebrolysin and Amantadine Sulfate Administration for Patients With Traumatic Brain Injury in the ICU
Efficacy of Prednisolone Versus Cerebrolysin in the Treatment of Bell's Palsy
Cerebrolysin REGistry Study in Stroke - a High-quality Observational Study of Comparative Effectiveness
CERebrolysin In CADASIL
Cerebrolysin in Critically Ill Patients With Delirium
Clinical Trials (32)
Combined Cerebrolysin and Amantadine Sulfate Administration for Patients With Traumatic Brain Injury in the ICU
Efficacy of Prednisolone Versus Cerebrolysin in the Treatment of Bell's Palsy
Cerebrolysin REGistry Study in Stroke - a High-quality Observational Study of Comparative Effectiveness
CERebrolysin In CADASIL
Cerebrolysin in Critically Ill Patients With Delirium
Clinical Characteristics and Treatment of Anosmia and Ageusia Due to SARS-CoV2 Variants
Cerebrolysin as an Add-On Therapy to Standard Treatment of Basilar Artery Occlusion
Exploring Cerebrolysin in Late Thrombectomy for Stroke: Blood-brain Barrier Biomarkers and Imaging Insights
Effect of Cerebrolysin on the Blood Brain Barrier in Patients With Diabetes and Ischemic Stroke
A Clinical Trial to Evaluate the Safety and Efficacy of 20 ml Cerebrolysin in Patients With Vascular Dementia
Cerebrolysin in Prevention of Postoperative Delirium in Cardiac Surgery
The Safety and Efficacy of Cerebrolysin in Patients With Acute Ischemic Stroke
CERebrolysine Effect on Blood-brain Barrier in acUte Ischemic Stroke
A Prospective, Trial About Safety and Efficacy of Combined Treatment With Cerebrolysin in Acute Ischemic Hemispheric Stroke Patients Undergoing EndoVascular Treatment (EVT)
Efficacy and Safety of Cerebrolysin on Prolonged Disorders of Consciousness
Evaluation of the Effect of Neuroprotective Drug on Treatment Result in Patients After Traumatic Brain Injury
Cerebrolycin for Treatment of Covid-related Anosmia and Ageusia
Efficacy of Cerebrolysin Treatment as an add-on Therapy to Mechanical Thrombectomy in Acute Ischemic Stroke.
IMPULSE - StIMulation of Brain Plasticity to Improve Upper Limb Recovery After StrokE
Cerebrolysin REGistry Study in Stroke
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 32